If you have liver disease including hepatitis B or C, your liver disease may get worse when you take anti-HIV medicines like REYATAZ atazanavir sulfate ; . some patients with hemophilia have increased bleeding problems with protease inhibitors like REYATAZ. changes in body fat. These changes may include an increased amount of fat in the upper back and neck "buffalo hump" ; , breast, and around the trunk. Loss of fat from the legs, arms, and face may also happen. The cause and long-term health effects of these conditions are not known at this time. Other common side effects of REYATAZ taken with other anti-HIV medicines include nausea; headache; stomach pain; vomiting; diarrhea; depression; fever; dizziness; trouble sleeping; numbness, tingling, or burning of hands or feet; and muscle pain. What important information should I know about taking REYATAZ with other medicines? Do not take REYATAZ if you take the following medicines not all brands may be listed; tell your healthcare provider about all the medicines you take ; . REYATAZ may cause serious, life-threatening side effects or death when used with these medicines. Ergot medicines: dihydroergotamine, ergonovine, ergotamine, and methylergonovine such as CAFERGOT, MIGRANAL, D.H.E. 45, ergotrate maleate, METHERGINE, and others used for migraine headaches ; . HALCION triazolam, used for insomnia ; . VERSED midazolam, used for sedation ; . ORAP pimozide, used for Tourette's disorder ; . PROPULSID cisapride, used for certain stomach problems ; . Do not take the following medicines with REYATAZ because of possible serious side effects: CAMPTOSAR irinotecan, used for cancer ; . CRIXIVAN indinavir, used for HIV infection ; . Both REYATAZ and CRIXIVAN sometimes cause increased levels of bilirubin in the blood. Cholesterol-lowering medicines MEVACOR lovastatin ; or ZOCOR simvastatin ; . Do not take the following medicines with REYATAZ because they may lower the amount of REYATAZ in your blood. This may lead to an increased HIV viral load. Resistance to REYATAZ or cross-resistance to other HIV medicines may develop: Rifampin also known as RIMACTANE, RIFADIN, RIFATER, or RIFAMATE, used for tuberculosis ; . St. John's wort Hypericum perforatum ; , an herbal product sold as a dietary supplement, or products containing St. John's wort. "Proton-pump inhibitors" used for indigestion, heartburn, or ulcers such as AcipHex rabeprazole ; , NEXIUM esomeprazole ; , PREVACID lansoprazole ; , PRILOSEC omeprazole ; , or PROTONIX pantoprazole ; . Do not take the following medicine if you are taking REYATAZ and NORVIR together. VFEND voriconazole ; . The following medicines may require your healthcare provider to monitor your therapy more closely: CIALIS tadalafil ; , LEVITRA vardenafil ; , or VIAGRA sildenafil ; . REYATAZ may increase the chances of serious side effects that can happen with CIALIS, LEVITRA, or VIAGRA. Do not use CIALIS, LEVITRA, or VIAGRA while you are taking REYATAZ unless your healthcare provider tells you it is okay. LIPITOR atorvastatin ; . There is an increased chance of serious side effects if you take REYATAZ with this cholesterol-lowering medicine. Medicines for abnormal heart rhythm: CORDARONE amiodarone ; , lidocaine, quinidine also known as CARDIOQUIN, QUINIDEX, and others ; . VASCOR bepridil, used for chest pain ; . COUMADIN warfarin ; . Tricyclic antidepressants such as ELAVIL amitriptyline ; , NORPRAMIN desipramine ; , SINEQUAN doxepin ; , SURMONTIL trimipramine ; , TOFRANIL imipramine ; , or VIVACTIL protriptyline ; . Medicines to prevent organ transplant rejection: SANDIMMUNE or NEORAL cyclosporin ; , RAPAMUNE sirolimus ; , or PROGRAF tacrolimus ; . The antidepressant trazodone DESYREL and others ; . Fluticasone propionate ADVAIR, FLONASE, FLOVENT ; , given by nose or inhaled to treat allergic symptoms or asthma. Your doctor may choose not to keep you on fluticasone, especially if you are also taking NORVIR. The following medicines may require a change in the dose or dose schedule of either REYATAZ or the other medicine: FORTOVASE, INVIRASE saquinavir ; . NORVIR ritonavir ; . SUSTIVA efavirenz ; . Antacids or buffered medicines. VIDEX didanosine ; . VIREAD tenofovir disoproxil fumarate ; . MYCOBUTIN rifabutin ; . Calcium channel blockers such as CARDIZEM or TIAZAC diltiazem ; , COVERA-HS or ISOPTIN SR verapamil ; , and others. BIAXIN clarithromycin ; . Medicines for indigestion, heartburn, or ulcers such as AXID nizatidine ; , PEPCID AC famotidine ; , TAGAMET cimetidine ; , or ZANTAC ranitidine ; . Women who use birth control pills or "the patch" should choose a different kind of contraception. REYATAZ may affect the safety and effectiveness of birth control pills or the patch. Talk to your healthcare provider about choosing an effective contraceptive. Remember: 1. Know all the medicines you take. 2. Tell your healthcare provider about all the medicines you take. 3. Do not start a new medicine without talking to your healthcare provider. How should I store REYATAZ? Store REYATAZ Capsules at room temperature, 59 to 86 F not store this medicine in a damp place such as a bathroom medicine cabinet or near the kitchen sink. Keep your medicine in a tightly closed container. Throw away REYATAZ when it is outdated or no longer needed by flushing it down the toilet or pouring it down the sink. General information about REYATAZ This medicine was prescribed for your particular condition. Do not use REYATAZ for another condition. Do not give REYATAZ to other people, even if they have the same symptoms you have. It may harm them. Keep REYATAZ and all medicines out of the reach of children and pets. This summary does not include everything there is to know about REYATAZ. Medicines are sometimes prescribed for conditions that are not mentioned in patient information leaflets. Remember no written summary can replace careful discussion with your healthcare provider. If you would like more information, talk with your healthcare provider or you can call 1-800-321-1335. What are the ingredients in REYATAZ? Active Ingredient: atazanavir sulfate Inactive Ingredients: Crospovidone, lactose monohydrate milk sugar ; , magnesium stearate, gelatin, FD&C Blue #2, titanium dioxide, black iron oxide, red iron oxide, and yellow iron oxide. VIDEX and REYATAZ are registered trademarks of Bristol-Myers Squibb Company. COUMADIN and SUSTIVA are registered trademarks of Bristol-Myers Squibb Pharma Company. DESYREL is a registered trademark of Mead Johnson and Company. Other brands listed are the trademarks of their respective owners and are not trademarks of Bristol-Myers Squibb Company.
2004, Regents of the University of California Nautilus is published quarterly by the faculty and staff of the Osher Center for Integrative Medicine at UCSF. If you have suggestions or would like information, please contact us at ocim ocim.ucsf . Please feel free to pass this newsletter on to a colleague.
The results are shown alongside those of a group of healthy controls in figure 2b. 4-02-08 PREVIDENT MEGACE ES SUSP. FENOGLIDE ATRALIN PROTONIX PAK NOXAFIL folbee plus CZ DIATX Equiv ; EVAMIST RENVELA sodium sufacetamide sulfur wash ROSAC Equiv ; TOPAMAX HUMALOG KWIKPEN METANX REPLIVA TEKTURNA ALTACE meloxicam MOBIC Equiv ; meloxicam MOBIC Equiv ; DEPLIN PLAVIX TAB 300mg INTELENCE M A A Ears and Throat Change from C 3 to Tier 2.

The rationale to support a conclusion that the claimed invention would have been obvious is that design incentives or other market forces could have prompted one of ordinary skill in the art to vary the prior art in a predictable manner to result in the claimed invention. If any of these findings cannot be made, then this rationale cannot be used to support a conclusion that the claim would have been obvious to one of ordinary skill in the art.

Keep GERD manageable. They work best when there is food in the stomach. Studies have shown that at least 93% of GERD patients are benefited by this class of drugs. The products available are omeprazole Prilosec ; , lansoprazole Prevacid ; , pantropazole Orotonix ; , rabeprazole Aciphex ; , and esomeprazole Nexium ; . These medications require a prescription from your physician, and several similar new products are presently becoming available. Although these drugs can virtually eliminate many of the distressing symptoms of GERD, they can not fully control regurgitation; that has to be controlled by lifestyle modifications. Antacids are also very important, because they help lessen the effects of excess acid in the GI tract. Readily available, inexpensive, and mostly without negative side effects, antacids can be utilized to coat the esophagus and stomach a few times per day, and specifically, when trouble may be anticipated. Gaviscon is a drug that can provide a unique beneficial function. This tablet foaming agent must be chewed and taken with water to put a protective barrier between the stomach and the esophagus; it works quite well to temporarily keep the acid in its place. So, if you're `feeling the burn' in a bad way, you may wish to make some of the recommended lifestyle changes outlined above. If the symptoms of GERD persist, you may wish to ask your physician about it. Resolving reflux and heartburn symptoms will not only allow you to focus on "feeling the burn" in your muscles, but it will make your swimming experience much more productive and enjoyable. Ed Nessel is a pharmacist, biochemist, and physiologist. He has been an active member of the USMS Sports Medicine and Coaches Committees, the USMS national librarian, and a recipient of the 1998 USMS Coach of the Year Award. He is also head coach of the Rutgers University Masters Swim Team and a member of Garden State Masters. References 1. DeVault, KR, Sastell, DO; Practice Guidelines: Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. J Gastroenterol, 1999; 94: 14341442. Pegnini, PL, Katz, PO, Bracy, NA, Castell, DO; Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. J Gastroenterol, 1998; 93: 763-767. Fouad, YM, Katz, PO, Castell, DO; Oseophageal motility defects associated with nocturnal gastro-oesophagel reflux on proton pump inhibitors. Ailment Pharmacol Ther, 1999; 13: 1467-1471. Robinson, M, Rodriguez-Stanley, S; H2-Receptor antagonists revisited: current role in the treatment of gastroesophageal reflux disease. CME Medscape Gastroenterology Treatment Updates and bentyl.

Not on formulary because does not meet the definition of see physician a Part D drug under CMS regulations Not on 2008 formulary enalapril, lisinopril, quinapril, Altace, Zestril Not on formulary because does not meet the definition of see physician a Part D drug under CMS regulations If drug taken in 2007, coverage will occur until 2008 at omeprazole, Nexium, the third tier copay or co-insurance. These drugs are not Protoniz listed on the 2008 formulary Not on formulary, generic s ; available Generic Available Not on formulary, generic s ; available Not on 2008 formulary Not on 2008 formulary Not on 2008 formulary On formulary, lower tier Generic Available see physician Prempro, Premphase Actonel On formulary, lower tier. ACIPHEX is a medicine called a proton pump inhibitor or an "acid pump inhibitor". This means it reduces the amount of acid that is made by your stomach. ACIPHEX is used in adults: for the short-term 4 to 8 weeks ; treatment in the healing and symptom relief of damaging erosive ; Gastroesophageal Reflux Disease GERD ; . to maintain healing of damage erosions ; and relief of heartburn symptoms with GERD. ACIPHEX has not been studied for treatment lasting longer than 12 months 1 year ; . for the treatment of day-time and night-time heartburn and other symptoms that happen with GERD. for short-term treatment up to 4 weeks ; in the healing and relief of stomach-area duodenal ; ulcers. The duodenal area is the area where food passes when it leaves the stomach. The main symptom of a duodenal ulcer is a steady pain in the stomach area. with certain antibiotic medicines for the treatment of an infection caused by bacteria called H. pylori. Sometimes H. pylori bacteria can cause duodenal ulcers. The infection needs to be treated to prevent the ulcers from coming back. for the long-term treatment of conditions where your stomach makes too much acid. This includes a condition called Zollinger-Ellison syndrome. Your stomach needs acid to help your body digest food. Stomach acid is made by tiny acid pumps in the cells that line your stomach. If your body makes too much acid or cannot protect itself against a normal amount of acid, medical problems such as GERD can happen. GERD happens when acid in your stomach backs up into the tube esophagus ; that connects your mouth to your stomach. Stomach acid can damage erode ; the lining of your esophagus. Some symptoms of GERD are heartburn, sour taste in the back of your throat and burping. Who should not take ACIPHEX? Do not take ACIPHEX if you: are allergic to any of the ingredients in ACIPHEX. The active ingredient is rabeprazole sodium. See the end of this leaflet for a complete list of ingredients in ACIPHEX. are allergic to any other medicines called proton pump inhibitors. The other proton pump inhibitor medicines include lansoprazole Prevacid ; , omeprazole Prilosec, Zegerid ; , esomeprazole Nexium ; and pantoprazole Prot9nix ; . What should I tell my doctor before I take ACIPHEX? and zantac!

TABLE 2. NEW DOSAGE FORMS AND INDICATIONS APPROVED BY THE FDA: MARCH 1MAY 25, 2001 Generic Name New Dosage Forms Albuterol Lansoprazole Clemastine fumarate, pseudoephedrine, acetaminophen Pantoprazole Ventolin HFA GlaxoSmithKline ; Prevacid Tap ; Tavist Allergy Sinus Headache Novartis ; Lrotonix IV Wyeth-Ayerst ; Chlorofluorocarbon-free metered dose inhaler New delayed-release oral suspension Temporary relief of symptoms associated with hay fever, allergic rhinitis, and the common cold. Inhaler 5 01 ; Suspension 5 01 ; Caplet 3 01 ; Brand Name Company ; Indication Dosage Form Date and allopurinol.
Case 1: Reducing waste through personalized dosage management Appropriate Factor VIII dosing for hemophilia patients depends on the individual product prescribed, the location and severity of the bleeding episode, and the body weight of the patient.6 Factor concentrates are not provided in consistent dosages, but in varying assay ranges, so products need to be selected carefully. Reconstituted factor must be infused within 3 hours, so full vials--rather than a portion of a vial--need to be administered to reduce the likelihood of waste. In order to fill prescriptions in the most cost-effective manner, it is necessary to maintain a robust inventory of different factor concentrates so that the vial sizes most closely matching the desired dosage can be used to fill the prescription. Although administering a higher dose than necessary will not harm the patient, overutilization of factor concentrates can increase annual treatment costs by 12% to 25%.6 A specialty pharmacy that can provide good factor assay matching can save plan sponsors a significant amount of money. The following are the results of a quarterly report for a large health plan client of Accredo Health. Following are the formulary changes that were discussed and approved at the HealthAmerica & Coventry Health Care P&T Committee meetings in 2002. This list was updated as of November 15, 2003. Table 1. Formulary Additions effective immediately ; Advicor Blocadren * Mavik Aldoril * Darvon * Mevacor * Apresazide * Darvocet-N-50 * Nasalide * Avelox Diuril * Ortho-Evra Azulfidine EnTabs * Lantus Prilosec ~ Benicar * Available generically Requires Prior Authorization Prilosec will be added to the formulary effective January 2003 Table 2. Formulary Deletions effective January 2003 with Alternatives Non Formulary Agent Formulary Alternatives Altace Prinivil * , Vasotec * , Accupril, Mavik Desoxyn Ritalin * , Adderall * , Dexedrine * Metadate CD Concerta, Ritalin * , Ritalin SR Micardis & Micardis HCT Benicar, Cozaar, Hyzaar Novo Brand Insulins Lilly Brand Insulins Prevacid Prilosec , Proonix Nasacort & AQ Flonase & Nasonex Rhinocort & AQ Flonase & Nasonex Tri-Nasal Flonase & Nasonex Vancenase & AQ Flonase & Nasonex The following drugs will require prior authorization in 2002 2003. Prior Authorization Agents for 2003 Actos pioglitazone ; Avandia rosiglitazone ; open benefits only Proton Pump Inhibitors - formulary Prilosec, Protonix ; Proton Pump Inhibitors - non formulary Aciphex, Nexium, & Prevacid ; open benefits only Blood Glucose Monitors Lifescan only ; Rebetol ribavirin ; Diflucan fluconazole ; Sporanox tablets and oral solution itraconazole ; Gleevec imatinib ; Temodar temozolomide ; Insulin Pens Novopen, Humulin Pen, etc ; Thalomid thalidomide ; Lamisil Oral terbinafine ; Tracleer bosentan ; OxyContin oxycodone sustained release ; Viagra sildenafil ; Single Dose Diflucan 150mg tablets do not require prior authorization Italics indicate non-formulary agents The following drugs will require prior authorization if the condition is not met when the pharmacist would attempt to transmit a prescription claim. Stepped Therapy Drugs for 2003 Drug Pulmicort Respules budesonide ; Protopic Ointment tacrolimus ; Zyprexa olanzapine ; Condition PA required between ages 5 & 8; not covered over age 8 Prior prescription for a medium to high potency topical steroid Prior prescription for a formulary atypical antipsychotic Examples include Risperdal or Seroquel Procardia XL * Soma Compound * Tracleer Valcyte Wygesic and ranitidine. Labs.2 ; has been widely prescribed for more than 25 years as.

I on a week course of the protonix and see my reg and prevacid.

EPLAN Software & Service, tools from third-party suppliers may also be incorporated. This is the next step toward greater integration and direct interaction between the disciplines. Interaction is the key Machinery and plant are mechatronic system solutions. Each participating discipline must be individually suited to the respective product requirement in order to function correctly. The control software must be just as functional and convincing as the hardware concept. The same goes for sensors, actuators, cabling, enclosure configuration, or hosing between fluid components. However, this in itself is not enough: Ultimately, the challenge lies in the interaction between these isolated solutions. Effective, holistic engineering cannot be achieved without functioning interaction. Discipline-specific engineering a thing of the past Most engineering is the result of individual, discipline-related activities. In the past, this meant that isolated CAx solutions designed for the specific application in question were used. However, certain types of data may be used on a cross-disciplinary basis, which inevitably leads us to consider ways of gaining access to such data via the use of corresponding interfaces, for example. Nevertheless, certain restrictions remain, such as data inconsistencies or the technical linking of data between disciplines. Summary: Former stand-alone disciplines are now combined into a powerful, all-round engineering approach - using the same database, making them more secure, faster and more efficient than ever before. EPLAN Electric P8, EPLAN Fluid and EPLAN PPE, all running on a uniquely integrated platform, will be introduced for the first time at this year's HMI. For more information, logon to : eplan . Click here to return to Contents Sequence, Arithmatica Partner to Advance SoC Low-Power Design; Promise Significant Power Improvements With Combined Approach 12 April 2006 Sequence Design announces that Arithmatica, Inc. has joined its In-Sequence Technology Partner Program, permitting the two companies to significantly advance SoC low-power design technologies and methods. The In-Sequence Program promotes technology advances for power-aware design flows, modeling accuracy, EDA interoperability and research through the alignment of technology partners and academia. "Working together lets us ensure SoC designers can efficiently and confidently use both CellMath, for datapath, and PowerTheater, for a variety of intellectual property IP ; blocks and full chip, to achieve significant power improvements, " said Tony Curzon Price, Arithmatica CEO. Arithmatica has introduced version 3.0 of the CellMath datapath design tools, incorporating powerknowledgeable synthesis and an extended Verilog interface capable of specifying robust datapath and zyloprim.

New generic medications are now available for the brand-name medications listed below. If you have HealthChoice members taking any of these brand-name medications, please note that the generic medication will save them money at the pharmacy. This applies to all HealthChoice members, including Medicare Supplement With and Without Part D members. Brand-Name Medication Colazal 750 mg Capsules Fosamax Kytril 1 mg Tablets Protonix Generic Medication balsalazide disodium capsules alendronate sodium granisetron hydrochloride pantoprazole sodium Treatment Ulcerative colitis Osteoporosis Acute nausea Acid reflux disease Date Available 12 31 2007.
Here are the prescription drugs in the ppi family: esomeprazole nexium ; , lansoprazole prevacid ; , pantoprazol protonix ; , rabeprazole aciphix ; and the over-the-counter ppi, omeprazole prilosec and proventil and Protonix online. NDA 20-988 S-031 Page 5 Drug-Drug Interactions Pantoprazole is metabolized mainly by CYP2C19 and to minor extents by CYPs 3A4, 2D6 and 2C9. In in vivo drug-drug interaction studies with CYP2C19 substrates diazepam [also a CYP3A4 substrate] and phenytoin [also a CYP3A4 inducer] ; , nifedipine, midazolam, and clarithromycin CYP3A4 substrates ; , metoprolol a CYP2D6 substrate ; , diclofenac, naproxen and piroxicam CYP2C9 substrates ; and theophylline a CYP1A2 substrate ; in healthy subjects, the pharmacokinetics of pantoprazole were not significantly altered. It is, therefore, expected that other drugs metabolized by CYPs 2C19, 3A4, 2D6, and 1A2 would not significantly affect the pharmacokinetics of pantoprazole. In vivo studies also suggest that pantoprazole does not significantly affect the kinetics of other drugs cisapride, theophylline, diazepam [and its active metabolite, desmethyldiazepam], phenytoin, warfarin, metoprolol, nifedipine, carbamazepine, midazolam, clarithromycin, naproxen, piroxicam and oral contraceptives [levonorgestrel ethinyl estradiol] ; metabolized by CYPs 2C19, 3A4, 2D6, and 1A2. Therefore, it is expected that pantoprazole would not significantly affect the pharmacokinetics of other drugs metabolized by these isozymes. Dosage adjustment of such drugs is not necessary when they are co-administered with pantoprazole. In other in vivo studies, digoxin, ethanol, glyburide, antipyrine, caffeine, metronidazole, and amoxicillin had no clinically relevant interactions with pantoprazole. Although no significant drug-drug interactions have been observed in clinical studies, the potential for significant drug-drug interactions with more than once daily dosing with high doses of pantoprazole has not been studied in poor metabolizers or individuals who are hepatically impaired. Pharmacodynamics Mechanism of Action Pantoprazole is a proton pump inhibitor PPI ; that suppresses the final step in gastric acid production by covalently binding to the H + , K -ATPase enzyme system at the secretory surface of the gastric parietal cell. This effect leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus. The binding to the H + , K -ATPase results in a duration of antisecretory effect that persists longer than 24 hours for all doses tested. Antisecretory Activity The magnitude and time course for inhibition of pentagastrin-stimulated acid output PSAO ; by single doses 20 to 120 mg ; of PROTONIX I.V. for Injection were assessed in a single-dose, open-label, placebo-controlled, dose-response study. The results of this study are shown in the table below. Healthy subjects received a continuous infusion for 25 hours of pentagastrin PG ; at 1 dose known to produce submaximal gastric acid secretion. The placebo group showed a sustained, continuous acid output for 25 hours, validating the reliability of the testing model. PROTONIX I.V. for Injection had an onset of antisecretory activity within 15 to 30 minutes of administration. Doses of 20 to mg of PROTONIX I.V. for Injection substantially reduced the 24-hour cumulative PSAO in a dose-dependent manner, despite a short plasma elimination half-life. Complete suppression of PSAO was achieved with 80 mg within approximately 2 hours and no further significant suppression was seen with 120 mg. The duration of action of PROTONIX I.V. for Injection was 24 hours.
I had forbidden protonix and potassium it and prednisolone.
The American Gastroenterology Association recommends that patients first try lifestyle modifications and over-the-counter medicines before Proton Pump Inhibitor or "PPI" drugs. PPI drugs are used to treat gastroesophageal reflux disease [GERD] as well as other diseases. GERD causes heartburn and acid regurgitation, which can wear away the lining of the esophagus. Expert doctors recommend other drugs, such as H-2 Antagonists as the first medicine to take with this condition. According to the prescription records of BeneScript members, Proton Pump Inhibitors or "PPI's" BeneScript members take on average 1.09 doses of their PPI daily the recommended dose is 1 dose daily ; . This excess consumption of PPI drugs results in healthcare dollars being spent unwisely. But this is only part of the story. Our lifestyle may be to blame. But why should I change my lifestyle.why not just take a pill? Often times, it is our lifestyle that leads to inappropriate consumption of drugs in the PPI class. Doctors urge lifestyle changes like avoiding the foods, beverages, and medicines that aggravate heartburn. Spicy foods, alcohol and caffeine all tend to decrease ter, located just above the stomach, essentially keeps stomach acid in its place and out of the esophagus. Doctors also recommend losing weight if you are overweight. Out of shape abdominal muscles permit more acid reflux. Overnight GERD can be decreased if you eat all meals at least 3 hours before bedtime. Drugs in the PPI category: Aciphex Nexium Prevacid Prilosec Protonix Drugs in the H-2 Antagonist Category: Axid Pepcid Tagamet Zantac cimetidine ranitidine famotidine. Provide a Wide Field of Vision Protect Eyes From Every Angle Flexible temples to fit All Head Sizes Comfortably Superior Optical Clarity Regular size infection control goggle designed to fit comfortably over prescription glasses. 370-0002125-00 2.50. Page16 DOSAGE AN5 ADMlNISTRATlON PROTONIX IV. for Injection may be administered intravenously through a dedicated line or through a Y-site. The intravenous line should be flushed before and after administration of PROTONIX I.V. for Injection with either 5% Dextrose Injection, USP, 0.9% Sodium Chloride Injection, USP, or Lactated Ringer' Injection, USP., When administered through a Y-site, PROTONIX IV. for Injection is s compatible with the following solutions: 5% Dextrose Injection, USP, 0.9% Sodium Chloride Injection, USP, or Lactated Ringer' Injection, WSP. s Midazolam HCl has been shown to be incompatible with Y-site administration of PROTONIX IV. for Injection. PROTONIX IV. for Injection may not be compatible with products containing zinc. When PROTONIX IV. for injection is administered through a Y-site, immediately stop use if precipitation or discoloration occurs. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to and during administration whenever solution and container permit. Treatment with PROTONIX I.V. for injection should be discontinued as soon as the patient is able to resume treatment with PROTONIX Delayed-ReleaseTablets. Also, data on the safe and effective dosing for conditions other than those described in INDICATKINS AND USA.GE, such as lifethreatening upper gastrointestinal bleeds, are not available. PROTONIX I.V. 40 mg once daily does not raise gastric pH to levels suffkient to contribute to the treatment of such life-threatening condkions. Parenteral routes of administration other than intravenous are not recommended. No dosage adjustment is necessaryin patients with renal impairment, hepatic impairment, or for elderly patients. Doses higher than 40 mg day have not been studied in hepatically-impaired patients. No dosage adjustment is necessaryin patients undergoing hemodialysis. Treatment of Gastroesophageai Reflux Disease Associated With a History of Erosive Esophagitis The recommendedadult dose is 40 mgpantoprazole given once daity by intravenous infusion for 7 to 10 days. Safety and efficacy of PROTONIX I.V. for Injection as a treatment of patients with GERD and a history of erosive esophagitis for more than 10 days have not been demonstrated see ]NDICATIONS AND USAGE.
While american doctors perform one-and-a-half million cataract surgeries a year and then have to repeat half of those because the cataracts come back.

This study demonstrated that, after 10 days of repeated oral administration followed by 7 days of intravenous administration, the oral and intravenous dosage forms of PROTONIX 40 mg are similar in their ability to suppress MAO and BAO in patients having GERD with a history of erosive esophagitis See table below ; . Also, patients on oral PROTONIX who were switched to intravenous placebo experienced a significant increase in acid output within 48 hours of their last oral dose. However, at 48 hours after their last oral dose, patients treated with PROTONIX I.V. for Injection had a significantly lower mean basal acid output than those treated with placebo. ANTISECRETORY EFFECTS mEq h ; OF 40 mg PROTONIX I.V. for INJECTION AND 40 mg ORAL PROTONIX IN GERD PATIENTS WITH A HISTORY OF EROSIVE ESOPHAGITIS Parameter PROTONIX Delayed-Release Tablets DAY 10 6.49 n 30 0.80 n 30 PROTONIX I.V. for Injection DAY 7 6.62 n 23 0.53 n 23 Placebo I.V.

5. Castell DO, et al. Esomeprazole provides more effective healing than lansoprazole in GERD patients with erosive esophagitis EE ; [abstract]. J Gastroenterol. 2001; 96 9, suppl ; : S6. 6. Castell DO, et al. Esomeprazole is more effective than lansoprazole for treating daily and nocturnal heartburn in GERD patients with erosive esophagitis EE ; [abstract]. J Gastroenterol. 2001; 96 9, suppl ; : S6. 7. Porro GB. Efficacy of lansoprazole in the short- and long-term treatment of gastrooesophageal reflux disease: a systematic overview. Cochrane Library 1999; CRD #DARE980160. 8. Mee AS, et al. Rapid symptom relief in reflux esophagitis: a comparison of lansoprazole and omeprazole. Aliment Pharmacol Ther. 1996; 10: 757-63. Mulder CJ, et al. Lansoprazole 30mg versus omeprazole 40mg in the treatment of reflux esophagitis grade II, III and IV A Dutch multicenter trial ; . Eur J Gastroenterol Hepatol. 1996; 8: 1101-6. Mossner J, et al. A double-blind study of pantoprazole and omeprazole in the treatment of reflux esophagitis: a multicenter trial. Aliment Pharmacol Ther. 1995; 9: 321-6. Corinaldesi R, et al. Pantoprazole and omeprazole in the treatment of reflux esophagitis: a European multicenter study. Aliment Pharmacol Ther. 1995; 9: 667-71. Thjodleifsson B, et al. Rabeprazole 20mg is similar to omeprazole 20mg day in the treatment of erosive or ulcerative esophagitis [abstract]. Gastroenterology. 1997; 112: A312. 13. Nexium esomeprazole ; Product Information. AstraZeneca Pharmaceuticals L.P.: Wilmington, DE, April 2007. 14. Prilosec omeprazole ; Product Information. AstraZeneca Pharmaceutical L.P.: Wilmington, DE; April 2007. 15. Protonix pantoprazole ; Product Information. Wyeth Laboratories: Philadelphia, PA; December 2007. 16. Prevacid lansoprazole ; Product Information. Tap Pharmaceuticals Inc.: Lake Forest, IL; July 2007. 17. Aciphex rabeprazole ; Product Information. Eisai Co., Ltd.: Teaneck, NJ; February 2007. 18. Facts and Comparisons, Updated Monthly, A Wolters Kluwer Company, St. Louis, 2001. 19. Escourrou J, et al. Maintenance therapy with pantoprazole 20mg prevents relapse of reflux oesophagitis. Aliment Pharmacol Ther. 1999; 13: 1481-91. Prilosec ; , this drug class includes lansoprazole Prevacid ; , pantoprazole Protonix ; , esomeprazole Nexium ; , and rabeprazole Aciphex ; . PPIs are highly effective in controlling symptoms and healing esophagitis, and are used as maintenance therapy to prevent GERD flare-ups.30 In general, standard-dose PPIs will relieve symptoms and heal esophagitis in 85% to 90% of patients.50 Patients with GERD are advised to take the PPI immediately before breakfast.50 Prokinetic Agents--Instead of neutralizing stomach acid, prokinetic agents increase LES pressure, enhance gastric emptying, and improve peristalsis. Older prokinetics such as bethanechol Urecholine ; and metoclopramide Reglan ; are rarely used because of their side-effect profiles.23 Although cisapride Propulsid ; has been found to be equivalent to standard-dose H2RAs in relieving reflux symptoms and healing esophagitis, this medication has been associated with cardiac arrhythmias and is available on a limited basis. The manufacturer recommends that a baseline electrocardiogram be performed before cisapride therapy is started.51 Concurrent use of cisapride with agents that increase cisapride blood levels eg, macrolides, nefazodone, antifungals, certain AIDS medications ; or that predispose patients to fatal arrhythmias eg, class IA or class III antiarrhythmics; certain TCAs, tetracyclic antidepressants, or antipsychotics ; is contraindicated.51 Comparative Trials--Many studies and two meta-analyses involving prescription-strength medications have demonstrated that PPIs are more effective than other drug classes or placebo in relieving heartburn in patients with GERD or NERD. A randomized, double-blind trial conducted on 310 patients who received omeprazole 20 mg daily or cimetidine 400 mg 4 times daily revealed that after 4 weeks of treatment, a significantly larger proportion of omeprazole recipients than cimetidine recipients were asymptomatic 46% vs 22%; P 0.001 ; .52 In addition, diary cards completed during the first 2 weeks showed that omeprazole users experienced fewer daytime and night-time symptoms.
Generally, Platinum Prime Plan will only approve your request for an exception if the alternative drugs included on the plan's formulary, the low-tiered drug or additional utilization restrictions would not be as effective in treating your condition and or would cause you to have adverse medical effects. You should contact us to ask us for an initial coverage decision for a formulary, tiering or utilization restriction exception. When you are requesting a formulary, tiering or utilization restriction exception you should submit a statement from your physician supporting your request. Generally, we must make our decision within 72 hours of your request. What are generic drugs? Platinum Prime Plan covers both brand-name drugs and generic drugs. A generic drug has the same active-ingredient formula as the brand name drug. Generic drugs usually cost less than brand name drugs and are approved by the Food and Drug Administration FDA ; . Generic drugs are listed in lower-case italics e.g., omeprazole ; within the formulary on page 6. Brand-name drugs are capitalized in the formulary e.g., PREVACID, PROTONIX ; . For more information For more detailed information about your Platinum Prime Plan prescription drug coverage, please review your Evidence of Coverage and other plan materials. If you have questions about Platinum Prime Plan, please call Customer Service at 1800-977-7339, Monday through Friday, 8: 00 to 5: pm. TTY TDD users should call 1-888-444-7352. Or visit vistahealthplan . If you have general questions about Medicare prescription drug coverage, please call Medicare at 1-800-MEDICARE 1-800-633-4227 ; 24 hours a day 7 days a week. TTY TDD users should call 1-877-486-2048. Or, visit medicare.gov. In this study, all PROTONIX treatment groups had significantly greater healing rates than the placebo group. This was true regardless of H. pylori status for the 20-mg and 40-mg PROTONIX treatment groups. The 40-mg dose of PROTONIX resulted in healing rates significantly greater than those found with either the 20- or 10-mg dose. According to the Company, the gathering of safety data comprised the follow$ng: recoding all side effects reported or noted during the~study, conducting a battery of routine and laboratory tests, ECG, and determination of blood pressure and heart rate values -- prior to the beginning of treatment i.e., baseline values ; and at intervals thereafter, whils administering either of the tested drugs in randomly assigned subjects. Noisy breathing when cries or supine, improves in prone position -feed him her in upright position ; unstable trauma patient, no bleeding source identifyable do dpl or us of abdomen; ct only when stable. Depending on the plan selected, the prescriptions below may result in an application being declined. The cost of a medication is considered a part of the insurance risk, regardless of the severity of the condition itself. Accutane Aciphex Advair Anti-coagulants within 12 months Anti-virals within 12 months Avelox Azmacort Azulfidine Celebrex Clarinex Clomid Concerta Depakote Evista Famvir Flovent Imdur Imitrex Immunosuppressant Drugs Intal Lamictal Lamisil Lipitor Lopid Lupron Maxalt Mevacor Nexium Parlodel Pravachol Prevacid Prilosec Propafenone Proscar Protonix Pulmicort Relafen Renova Serevent Singulair Steroids within 12 months Tambocor Temovate.
Our medication protonix used s downsize a clearance of narcissisms and pharmacist in suffice to regulate cheapest aurass feeble as pustules and classes.
The following is a list of some non-Preferred brand medications with examples of Preferred alternatives that are on the formulary. Column 1 lists examples of non-Preferred medications. Column 2 lists some alternatives that can be prescribed. Thank you for your compliance. Non-Preferred ACCOLATE [ST] ACEON [ST] ACIPHEX [ST] ACTONEL ACULAR PF AEROBID M ALAMAST ALOCRIL ALORA ALREX ALTOCOR AMARYL AMERGE [DQ] ANZEMET ASCENSIA [PA] ATACAND HCT [ST] AVALIDE AVAPRO [ST] AVINZA AVITA [PA] AXERT [DQ] AZELEX AZMACORT AZOPT BECONASE AQ BENICAR HCT [ST] BENZAMYCIN BETIMOL BIAXIN -XL CARDENE SR CARDIZEM LA CAVERJECT [DQ] CECLOR CD CEDAX CEFZIL CENESTIN CIALIS [DQ] CIPRO XR COVERA-HS DETROL -LA DIDRONEL DIPENTUM DYNABAC DYNACIRC CR EPOGEN [PA] ESTRADERM FAMVIR FERTINEX [inj] [PA] FLOXIN Fml FORTE FOCALIN FREESTYLE [PA] FROVA [DQ] GEODON GLUCOMETER [PA] GLYSET HELIDAC IOPIDINE KADIAN KETEK KRISTALOSE Preferred Alternative SINGULAIR benazepril, enalapril, lisinopril, ALTACE omeprazole, PREVACID, PROTONIX FOSAMAX, BONIVA VOLTAREN Ophthalmic QVAR, FLOVENT HFA, DISKUS cromolyn sodium, ALOMIDE, PATANOL, ZADITOR cromolyn sodium, ALOMIDE, PATANOL, ZADITOR generics, ESCLIM generic steroids lovastatin, CRESTOR, VYTORIN, simvastatin glimepiride IMITREX, ZOMIG ZMT ZOFRAN, KYTRIL ACCU-CHEK, ONE TOUCH DIOVAN HCT, HYZAAR, COZAAR HYZAAR, DIOVAN HCT, COZAAR generics DIFFERIN, generic tretinoin IMITREX, ZOMIG ZMT generics, DIFFERIN QVAR, FLOVENT HFA, DISKUS ALPHAGAN P NASACORT AQ, fluticasone DIOVAN HCT, HYZAAR, COZAAR erythromycin benzoyl peroxide betaxolol, timolol, other generics clarithromycin nifedipine extended release, amlodipine diltiazem extended release, VERELAN EDEX cefaclor extended release amox tr potassium clavulanate, AUGMENTIN XR cefdinir MENEST, PREMARIN LEVITRA ciprofloxacin, AVELOX verapamil extended release, VERELAN oxybutynin, VESICARE FOSAMAX, BONIVA ASACOL, PENTASA erythromycin nifedipine extended release, amlodipine ARANESP, PROCRIT generics, ESCLIM acyclovir, VALTREX GONAL-F ciprofloxacin, AVELOX generic steroids, LOTEMAX methylphenidate, CONCERTA ACCU-CHEK, ONE TOUCH IMITREX, ZOMIG ZMT ABILIFY, RISPERDAL non M-Tab ; , SEROQUEL, ZYPREXA non- Zydis ; ACCU-CHEK, ONE TOUCH PRECOSE PREVPAC ALPHAGAN P morphine sulfate clarithromycin, erythromycin lactulose Non-Preferred LESCOL XL [ST] LEXXEL [ST] LIPITOR [ST] LOPROX LORABID LUNESTA MAVIK [ST] MAXALT mlT [DQ] MAXAQUIN MIACALCIN NASAL MICARDIS HCT [ST] MOBIC [ST] MUSE [DQ] NASAREL NEXIUM [ST ; NOROXIN OPTIVAR ORAPRED OVIDREL OXYIR PCE PEDIAPRED PERGONAL [inj] [PA] PHENYTEK PLENDIL PRECISION [PA] PRILOSEC [PA] PROZAC WEEKLY [ST] QUIXIN RELENZA [DQ] RELPAX [DQ] RESCULA RETIN-A liquid MICRO [PA] RHINOCORT AQUA RISPERDAL M-TAB RITALIN LA RYNATAN SKELID SOF-TACT [PA] SPECTRACEF SPORANOX [PA] SULAR SUPRAX TARKA [ST] TESTIM TESTODERM TEVETEN HCT [ST] TOFRANIL-PM TRAVATAN TRI-NORINYL UNIRETIC [ST] VANTIN VEXOL VIAGRA [DQ] ZITHROMAX ZYFLO ZYPREXA ZYDIS ZYRTEC -D ZOCOR Preferred Alternative lovastatin, CRESTOR, VYTORIN, simvastatin amlodipine benazepril lovastatin, CRESTOR, VYTORIN, ADVICOR, simvastatin OTCs, MENTAX amox tr potassium clavulanate, AUGMENTIN XR SONATA, zolpidem benazepril, enalapril, lisinopril, ALTACE IMITREX, ZOMIG ZMT ciprofloxacin, AVELOX FOSAMAX, BONIVA DIOVAN HCT, HYZAAR, COZAAR generic NSAIDs EDEX NASACORT AQ, fluticasone omeprazole, PREVACID, PROTONIX ciprofloxacin, AVELOX PATANOL, ZADITOR prednisolone soln chorionic gonadotropin oxycodone hcl caps immediate release erythromycin prednisolone soln REPRONEX phenytoin sodium extended release nifedipine extended release, amlodipine ACCU-CHEK, ONE TOUCH omeprazole, PREVACID, PROTONIX citalopram, fluxotine daily ; , paroxetine, ZOLOFT ciprofloxacin, ofloxacin, VIGAMOX, ZYMAR rimantadine, TAMIFLU IMITREX, ZOMIG ZMT XALATAN generic, tretinoin NASACORT AQ, fluticasone RISPERDAL non M-tabs ; methylphenidate, CONCERTA, Metadate CD ER ALLEGRA -D FOSAMAX, BONIVA ACCU-CHEK, ONE TOUCH amox tr potassium clavulanate, AUGMENTIN XR itraconazole nifedipine extended release, amlodipine amox tr potassium clavulanate, AUGMENTIN XR verapamil + ACE Inhibitor, LOTREL ANDROGEL, ANDRODERM ANDROGEL, ANDRODERM DIOVAN HCT, HYZAAR, COZAAR imipramine tabs LUMIGAN ORTHO TRI-CYCLEN LO, generics benazepril HCTZ, enalapril hctz, lisinopril hctz amox tr potassium clavulanate, AUGMENTIN XR generic steroids, LOTEMAX LEVITRA azithromycin SINGULAIR ZYPREXA non-Zydis ; ALLEGRA -D * simvastatin.

Protonix adverse effects

Protonix and breastfeeding

Protonix more drug_warnings_recalls, protonix news, protonix long term effects, protonix leg pain and protonix weight loss. Protonix adverse effects, protonix and breastfeeding, protonix 40mg and protonix 100mg or protonix maximum dosage.

Protonix 40mg

Digoxin 0.25, orchitis std, superbug ear infection, gillies incision zygoma and quality of life of cancer patients. Detrol not working, paroxetine xet 20, quasi water park and psoriasis laser or apo lorazepam.